• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT VASCULAR XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM Back to Search Results
Model Number 1804350-28
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Angina (1710); Cardiac Arrest (1762); Respiratory Failure (2484); Thrombosis/Thrombus (4440)
Event Date 03/10/2023
Event Type  Death  
Manufacturer Narrative
Manufacturer's investigation is still pending at this time.Results and conclusions will be provided in the final report.
 
Event Description
It was reported that on (b)(6) 2022, a procedure was performed to treat lesions in the proximal and mid left anterior descending (lad) vessels.Two non-abbott stents were implanted in the first marginal and proximal to mid lad lesions.On (b)(6) 2023, restenosis was noted in the first marginal which was treated with a drug coated balloon.On (b)(6) 2023, restenosis was observed in the proximal to mid lad.The 3.5x28mm xience skypoint stent was implanted in the proximal to mid lad, overlapping the previously implanted stent for treatment.No abnormity was noted with the xience stent or flow after stent implantation.On (b)(6) 2023, the patient returned to the hospital.The patient was experiencing chest pain and was in a state of cardiopulmonary arrest (cpa).Imaging confirmed total occlusion from distal of the implanted xience stent.Thrombus aspiration was performed; however, did not aspirate much thrombus.Reperfusion was performed with balloon dilatation, but the patient did not recover.The following day the patient expired.No additional information was provided.
 
Event Description
Subsequent to the previously filed report, the following correction was made: prior to the restenosis noted on (b)(6) 2023, the order of events were as follows on (b)(6) 2022, a non-abbott stent was implanted in the stenosed lesion of the first marginal coronary artery.On (b)(6) 2022, a non-abbott stent was implanted in the proximal to mid left anterior descending (lad) coronary artery.
 
Manufacturer Narrative
The device was not returned for analysis.A review of the lot history record identified no manufacturing nonconformities issued to the reported lot that would have contributed to this event.The reported patient effect(s) of thrombosis, angina and death are listed in the xience skypoint everolimus eluting coronary stent systems instructions for use as a known patient effect(s) of coronary stenting procedures.A conclusive cause for the reported patient effect(s), and the relationship to the product, if any, cannot be determined; however, the subsequent treatment appears to be related to the operational context of the procedure.There is no indication of a product quality issue with respect to manufacture, design or labeling; therefore, no product-related corrective action will be implemented in this case.B5: describe event or problem.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
XIENCE SKYPOINT DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Type of Device
DRUG ELUTING CORONARY STENT DELIVERY SYSTEM
Manufacturer (Section D)
ABBOTT VASCULAR
26531 ynez rd.
temecula CA 92591 4628
Manufacturer (Section G)
ABBOTT VASCULAR, REG # 3005718570 (P099)
cashel road
clonmel tipperary
EI  
Manufacturer Contact
lindsey bell
26531 ynez rd.
temecula, CA 92591-4628
9519143996
MDR Report Key16685652
MDR Text Key312734063
Report Number2024168-2023-03542
Device Sequence Number1
Product Code NIQ
UDI-Device Identifier08717648233425
UDI-Public08717648233425
Combination Product (y/n)Y
Reporter Country CodeJA
PMA/PMN Number
P110019
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Foreign,Health Professional,Company Representative,Distributor
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 05/04/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received04/05/2023
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Model Number1804350-28
Device Catalogue Number1804350-28
Device Lot Number107194A
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received04/11/2023
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured07/26/2021
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age72 YR
Patient SexMale
Patient Weight68 KG
-
-